Jiang Xiaomeng: A Centennial Enterprise with Craftsman Spirit
Release time:
2020-07-31
Editor's Note: days ago, the United Front Work Department of Jinhua Municipal Committee, the Municipal Federation of Industry and Commerce and other units jointly launched a large-scale publicity campaign on "2016 Letter to Good Wu Merchants". 10# June 18 , Jinhua media reporters walked into the peak and made a collective interview with Chairman Jiang Xiaomeng. 10# October 21 , the front page of Jinhua Daily published the article "Jiang Xiaomeng: Strive for a Century of Enterprise with Craftsman Spirit" written by its reporter Zhang Shuai. This newspaper is reproduced.
58 , Chairman Jiang Xiaomeng's face is filled with passion and confidence.
58 years, the peak has experienced ups and downs. Every time it encounters a major turning point, generations of "peak people" have opened a new chapter with tireless efforts and simple wisdom.
11.03 .6 billion yuan, up 4.15% over the same period of last year; Net profit attributable to owners of the parent company reached 1.03 billion yuan, up 12.9 year on year. These data in the current weak domestic economic development, has become more prominent.
58 years, and are also the models of our "wushang" group to stick to industry, operate in good faith and serve the country by industry.
58 years ago, bearing in mind the history of the peak, can be seen at a glance by many old Jin Chinese. This is the original site of the Wisdom Temple in the north of Jinhua City. The place was small and desolate. The first group of pioneers built the first cement factory in Jinhua with their hands and blood.
20 years old, he walked into the gate of the cement factory and is now leading thousands of people to fight the business world. Jiang Xiaomeng said that this is the common growth and achievement of individuals and enterprises. 1993
28 , unusual for Jianfeng Group. On this day, Jianfeng stock started trading on the Shanghai Stock Exchange and became the country's first listed company in the cement industry, which laid the foundation for the standardized management and further development of Jianfeng Group. to 2006
2007 , the cement market competition is extremely fierce, coupled with the state's policy restrictions on the closure of mechanical vertical kilns, many cement plants have lost their competitiveness. Spikes are also facing harsh realities, and benefits are plummeting. At this key node, Jianfeng cooperated with central enterprises in a timely manner to transfer the equity of cement enterprise 65% in Zhejiang Province, set up Southern Cement, became one of the sponsors of Southern Cement, and invested limited funds in the central and western regions with more advantages in market prospects, resources and supply. After the most difficult period from 2006 to
, Jianfeng promptly established the development policy of "strengthening the main business through cooperation and innovation, standardizing science and seeking development", and became an industrial pattern with cement and medicine as the two main businesses, bonded logistics as the supplement, and multiple investments in concentric related industries as the supplement, which further clarified the industrial positioning of the group, be a niche in the cement market, a leader in the pharmaceutical industry segment, and a leader in health product innovation. Jiang Xiaomeng said that these decisions are strategic choices made in combination with the actual situation of the peak and the development trend, and are the self-adjustment of the peak group on the road of development. Only when the positioning is accurate and the goal is clear can an enterprise have the driving force for sustainable development.
Looking forward to the future, driven by innovation in medicine and health, the industry is booming
. Besides complementing cement and having a broad market, Jiang Xiaomeng hopes to stimulate the vitality of the peak through medicine and health.
During the peak years of
, Jiang Xiaomeng knew very well that innovation and development are the best catalysts for enterprises to maintain vitality. To be brave, transformation and upgrading are the best driving forces. The medical and health industry is also one of the most obvious industries driven by scientific and technological innovation. Jianfeng Pharmaceutical has always paid attention to the innovative research and development of pharmaceutical products. It has two professional research institutions and a provincial new drug research and development center. At the same time, it has
academician expert workstations and 3 postdoctoral mobile stations in the field of plant extracts and chemical pharmaceuticals respectively, and has obtained more than 20 national invention patents . This has laid a solid foundation for the innovation of peak pharmaceutical products. Many products of Jianfeng Pharmaceutical have been listed as national high-tech industrialization demonstration project, national key new product plan project and national torch plan project, and have been rated as national high-tech enterprises for 10 years in a row. In addition, with the deepening of the management of pharmaceutical commercial circulation order, the peak will effectively integrate the existing internal circulation enterprises in the field of circulation, and constantly improve the profitability and business model with innovative thinking, so as to make the pharmaceutical circulation enterprises more standardized, more orderly and stronger, and further enhance their competitiveness. Jianfeng Health Technology Co., Ltd. is another major layout of Jianfeng Group in the field of health in recent years. Entering the company's laboratory, high-tech experimental equipment can be seen everywhere. In front of a piece of equipment, Yu Hongjian, general manager of the Health Technology Company, told reporters that this is the first production equipment used in ginkgo extract in China. The entire production process is operated and monitored in real time by the computer system in the central control room to minimize Human errors and risks ensure stable and safe product quality. In the central control room, the reporter also saw two staff members staring at the large computer screen all the time, paying attention to the changes in the monitoring values on the screen.
In the Peak Health Experience Hall, Jiang Xiaomeng introduced that the big health industry is a very broad concept, including health care products, health care for the aged, health care, etc. With the improvement of people's living conditions, people's demand will be more and more big. The human demand for health, health care and longevity is an irreversible trend and trend. The positioning of the peak for the big health industry is: natural raw materials, ancient and modern use, changing tradition into fashion, and being a leader in health product innovation. Around this concept, Spike has done a lot of work in innovative decoction pieces and has obtained a number of patents, for example, many people know that eating Gastrodia elata is good, but the texture of Gastrodia elata is hard, how to eat it? Spike Health makes Gastrodia elata slices that dehydrate and freeze-dry slices of fresh Gastrodia elata, which is as simple and convenient as eating potato chips. There are also freeze-dried ultra-fine powder of noto-ginseng, freeze-dried Dendrobium, heart-shaped Astragalus tablets and so on.
listed
years, Jianfeng Group's total assets have increased from 1.38 .2 billion yuan at the beginning of listing to 35.78 .4 billion yuan now, and its net assets have increased from less than 1 .6 billion yuan to 22.01 .8 billion yuan, increasing nearly 26 times and 22 times respectively. operates in good faith, sticks to industry, and does not forget social responsibility
In the Jianfeng History Showroom, photos with historical accumulation make people feel that Jianfeng Group is working hard and at the same time, they also see Jianfeng's active social responsibility. Since the listing of
, the peak tax payment and social security payment have exceeded
.3 billion yuan, which has been a major taxpayer of enterprises in Jinhua for many years. Jianfeng Group, Jianfeng Pharmaceutical, Jianfeng Cement and other holding companies were rated as Zhejiang Province 3A -class contract-abiding and trustworthy units, integrity management enterprises. Jianfeng Group has just won the silver award of "Zhejiang Industry Award" in 2016 this year, and is the second batch of "three" cultivation pilot enterprises in Zhejiang Province. Jianfeng Group has also carried out fruitful work in enterprise pairing, thousand enterprise pairing, and employee labor security. It has been rated as an advanced ideological and political work unit in Zhejiang Province and Jinhua City for many years. started from
April with a donation of of 20 .56 million yuan to build "Zhejiang Jianfeng Hope Primary School" (the first Hope Primary School on the "Roof of the World" aided by an enterprise) in Nagqu District of Tibet Autonomous Region. Jianfeng Group's "Hope" road lasted for 21 years. In the meantime, 8 Hope Primary School, which was built with high-end donations, has sprung up. Its donation areas cover Tibet, Gansu, Yunnan and our Jinhua region.
.5 billion yuan in environmental protection technological transformation funds exceeding . Because ecological development has been implanted into corporate culture, many important activities can always see the figure of the peak, such as Jinhua five water co-governance, Wenchuan earthquake relief, Jinhua Red Cross donation AED automatic defibrillator and so on.
58 years, in addition to the upbringing of Jinhua, is also because the peak development has four cornerstones: a strong corporate culture, a development path suitable for itself, and an endogenous expansion desire that matches its own strength, there is a management team that highly identifies with the culture of spikes. "Our mission is to be a century-old peak, and generations of peak people will dream of the future with the spirit of craftsmen." ("Jinhua Daily" reporter Zhang Shuai)
More information
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-22
Peak International Trade was rated as "excellent delivery warehouse" by the big business"
On April 12, the 2019 Dalian Commodity Exchange Industrial Products Delivery Work Summary Meeting was held in Dalian. Jianfeng International Trading Company was rated as "2018 (Industrial Products) Excellent Delivery Warehouse" and Ruan Weihang, an employee of the International Trading Company, was rated as "2018 (Industrial Products) Excellent Futures Specialist in Designated Delivery Warehouse". The delivery link is the bridge link between the futures and cash markets, an important area of risk prevention and control in the futures market, and a strong guarantee for the smooth operation and function of the market. Since obtaining the qualification of PVC delivery warehouse in 2009, the chemical warehousing and logistics business of international trading company has developed steadily. In terms of management, the international trading company strictly follows the various systems of the Dalian Commodity Exchange to implement warehouse-in and warehouse-in management. The management level has been improved year by year. Broken packages have been handled on the spot, and the loss of goods has been greatly reduced. The management goal of daily clearing has been achieved, and standardized operations have been achieved; in terms of business marketing, the futures business has driven the gradual development and growth of the spot business, futures varieties have developed from a single PVC variety to four varieties of PVC, PP, PE and plywood. The business volume has increased year by year and has exceeded 500000 tons. The operation volume can exceed 2500 tons/day; In terms of customer service, from zero experience in futures business to now, customer reputation has increased year by year, and customer complaints have gradually decreased. The annual excellent delivery warehouse of the judges is the full affirmation of Dalian Commodity Exchange on the functions of international trading companies, market satisfaction, futures management level and standardization of warehouse daily management. Lou Chunming, general manager of the international trading company, said that the international trading company will implement
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-30
Peak Cement Won the Bid for National Key Project Daye Peak Becomes Huang-Huang Railway Supplier
On March 19, Daye Jianfeng Cement Company officially received a notice from China Railway Construction Material Collection Center that the company was shortlisted for the new Huang (Mei) Huang (Zhou) railway project in the Hubei section of the Shanghai-Chengdu high-speed railway along the Yangtze River in the second place, and obtained the right to supply the 6th package of cement. This is the first stick undertaken by Daye Jianfeng in 2019, and it is also the second time to enter the high-speed rail project after the Wu (Han) Jiu (Jiang) high-speed rail. The Huanghuang high-speed railway is a component of the "eight vertical and eight horizontal" high-speed railway network in the "National Medium and Long-term Railway Network Plan". It is a component of the Wuhan-Hangzhou and Beijing-Hong Kong-Kowloon high-speed railway network. It has a total length of 125 kilometers and a design speed of 350 kilometers per hour. It will start construction at the end of 2018. It will be opened to traffic in 2021. In addition to the characteristics of large demand for high-speed railway and highway projects, the project time span is long and the product quality requirements are high, especially the high-speed railway project has extremely strict requirements on the alkali content of cement. After participating in the bidding, Yuan Xianming, executive deputy general manager of Daye Peak, organized production, quality control, procurement and other relevant departments for many times to carry out tests on the production of low-alkali cement and adjust the proportion of raw materials. The quality control department also sent samples to the provincial professional inspection department for comparative inspection to ensure product stability. The marketing department carefully checked the details of the tender, strictly checked and repeatedly deduced the bid price. Finally, with the full cooperation of all departments, the successful bidding was passed, finalist Huang-Huang high-speed rail project. It is understood that as the country continues to increase investment in infrastructure transportation construction, daye peak adjusted its work direction at the end of 2018, requiring marketing work in 2019 to focus on key projects.
2020
07-31
Daye Peak Opens "Standard Year"
After the 2019 overhaul ended in early March, Daye Jianfeng Cement Company immediately launched the "Standard Year" activity to carry out standardized rectification in view of a series of defects and problems in the daily management process. The goal of the "Standard Year" activity is to target specific issues that affect employees' work efficiency and safe and environmentally friendly production. Through the formulation of institutionalized work standards, further standardize employees' various operations, improve operational efficiency, and improve grassroots management execution, so as to achieve The purpose of improving the company's image, reducing costs, improving efficiency, and increasing benefits. In order to ensure the smooth progress of the activities, daye peak has set up a promotion team headed by general manager Zhang fengliang to be responsible for the overall promotion of the "standard year" activities, mainly including revising the activity plan, summarizing the standardized implementation standards of various departments, implementing the plan, supervising the implementation progress, evaluating the implementation effect, collecting suggestions and opinions in the implementation process, etc. Based on the foundation, aiming at the details and solving problems is a major feature of Daye peak's "standard year" activity. For example, the "Flange Sealing Operation Standard", which is currently being tried out, not only puts forward standardization requirements for such a "trivial matter" in equipment management as flange sealing, but also attaches "model" photos to make it clear to mechanics What should be done and what should be done. However, this "small standard" aims at three problems: leakage at the production site, extensive mechanic work and waste of materials. Once it becomes the behavior habit of employees, the hygiene and cost control at the production site are bound to be improved. It is understood that Daye peak "standard year" activities plan to continue for three years to promote, activities
2020
07-22
Daye Peak Opens "Standard Year"
After the 2019 overhaul ended in early March, Daye Jianfeng Cement Company immediately launched the "Standard Year" activity to carry out standardized rectification in view of a series of defects and problems in the daily management process. The goal of the "Standard Year" activity is to target specific issues that affect employees' work efficiency and safe and environmentally friendly production. Through the formulation of institutionalized work standards, further standardize employees' various operations, improve operational efficiency, and improve grassroots management execution, so as to achieve The purpose of improving the company's image, reducing costs, improving efficiency, and increasing benefits. In order to ensure the smooth progress of the activities, daye peak has set up a promotion team headed by general manager Zhang fengliang to be responsible for the overall promotion of the "standard year" activities, mainly including revising the activity plan, summarizing the standardized implementation standards of various departments, implementing the plan, supervising the implementation progress, evaluating the implementation effect, collecting suggestions and opinions in the implementation process, etc. Based on the foundation, aiming at the details and solving problems is a major feature of Daye peak's "standard year" activity. For example, the "Flange Sealing Operation Standard", which is currently being tried out, not only puts forward standardization requirements for such a "trivial matter" in equipment management as flange sealing, but also attaches "model" photos to make it clear to mechanics What should be done and what should be done. However, this "small standard" aims at three problems: leakage at the production site, extensive mechanic work and waste of materials. Once it becomes the behavior habit of employees, the hygiene and cost control at the production site are bound to be improved. It is understood that Daye peak "standard year" activities plan to continue for three years to promote, activities
2020
07-31